Literature DB >> 25223842

Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems.

Joao Paulo Maia-de-Oliveira1, Bruno Lobão-Soares2, Glen B Baker3, Serdar M Dursun3, Jaime E C Hallak4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25223842     DOI： 10.1016/j.schres.2014.08.020

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  3 in total

1.  Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain.

Authors:  Mariana C Diana; Fernanda F Peres; Veronica Justi; Rodrigo A Bressan; Acioly L T Lacerda; José Alexandre Crippa; Jaime E C Hallak; Vanesssa Costhek Abilio
Journal:  CNS Neurosci Ther       Date:  2018-04-14       Impact factor: 5.243

2.  MK-801-induced impairments on the trial-unique, delayed nonmatching-to-location task in rats: effects of acute sodium nitroprusside.

Authors:  Jessica L Hurtubise; Wendie N Marks; Don A Davies; Jillian K Catton; Glen B Baker; John G Howland
Journal:  Psychopharmacology (Berl)       Date:  2016-10-10       Impact factor: 4.530

3.  Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia.

Authors:  Ludmyla Kandratavicius; Priscila Alves Balista; Daniele Cristina Wolf; Joao Abrao; Paulo Roberto Evora; Alfredo Jose Rodrigues; Cristiano Chaves; Joao Paulo Maia-de-Oliveira; Joao Pereira Leite; Serdar Murat Dursun; Glen Bryan Baker; Francisco Silveira Guimaraes; Jaime Eduardo Cecilio Hallak
Journal:  BMC Neurosci       Date:  2015-03-07       Impact factor: 3.288
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.